Gilead Sciences is a biopharmaceutical company which engages in the discovery, development, and commercialization of therapeutics to patients suffering from life-threatening diseases primarily in the United States.
| Registrars: |
| Address: | |
| Phone: | |
| Fax: | |
| Website: | |
| Email: |
| ISIN: | US3755581036 |
| Main Indices: | S&P 500, Nasdaq 100, Nasdaq Composite, S&P 100 |